Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders

PH12021550882B1Active Publication Date: 2026-07-31OPUS GENETICS INC
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-04-20
Publication Date
2026-07-31
Patent Text Reader

Abstract

The invention provides methods, compositions, and kits containing an alphaadrenergic antagonist, such as phentolamine, for use in monotherapy or as part of a combination therapy to treat patients suffering from presbyopia, mydriasis, and / or other ocular disorders.
Need to check novelty before this filing date? Find Prior Art